This company is no longer active
Angion Biomedica Balance Sheet Health
Financial Health criteria checks 4/6
Angion Biomedica has a total shareholder equity of $39.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $41.8M and $2.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$29.22m |
| Equity | US$39.67m |
| Total liabilities | US$2.10m |
| Total assets | US$41.77m |
Recent financial health updates
Companies Like Angion Biomedica (NASDAQ:ANGN) Could Be Quite Risky
Apr 27
Angion Biomedica (NASDAQ:ANGN) Will Have To Spend Its Cash Wisely
Jan 05We Think Angion Biomedica (NASDAQ:ANGN) Needs To Drive Business Growth Carefully
Sep 11We Think Angion Biomedica (NASDAQ:ANGN) Can Afford To Drive Business Growth
Mar 19We're Hopeful That Angion Biomedica (NASDAQ:ANGN) Will Use Its Cash Wisely
Aug 18Recent updates
Companies Like Angion Biomedica (NASDAQ:ANGN) Could Be Quite Risky
Apr 27Angion Biomedica (NASDAQ:ANGN) Will Have To Spend Its Cash Wisely
Jan 05We Think Angion Biomedica (NASDAQ:ANGN) Needs To Drive Business Growth Carefully
Sep 11Angion Biomedica GAAP EPS of -$0.30, revenue of $0.7M misses by $0.08M
Aug 15Angion to discontinue phase 2 trial of ANG-3070 in patients with kidney disease
Jun 29We Think Angion Biomedica (NASDAQ:ANGN) Can Afford To Drive Business Growth
Mar 19Angion Biomedica: Selling At Cash Value
Feb 07Angion Biomedica Corp.'s (NASDAQ:ANGN) Intrinsic Value Is Potentially 49% Above Its Share Price
Oct 05We're Hopeful That Angion Biomedica (NASDAQ:ANGN) Will Use Its Cash Wisely
Aug 18Financial Position Analysis
Short Term Liabilities: ANGN's short term assets ($40.6M) exceed its short term liabilities ($2.0M).
Long Term Liabilities: ANGN's short term assets ($40.6M) exceed its long term liabilities ($70.0K).
Debt to Equity History and Analysis
Debt Level: ANGN is debt free.
Reducing Debt: ANGN has no debt compared to 5 years ago when its debt to equity ratio was 5.4%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ANGN has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ANGN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.7% each year